...
首页> 外文期刊>Alcohol and alcoholism: international journal of the Medical Council on Alcoholism >Combination pharmacotherapy: a mixture of small doses of naltrexone, fluoxetine, and a thyrotropin-releasing hormone analogue reduces alcohol intake in three strains of alcohol-preferring rats.
【24h】

Combination pharmacotherapy: a mixture of small doses of naltrexone, fluoxetine, and a thyrotropin-releasing hormone analogue reduces alcohol intake in three strains of alcohol-preferring rats.

机译:联合药物治疗:小剂量纳曲酮,氟西汀和促甲状腺激素释放激素类似物的混合物可减少三类酒精偏爱大鼠的酒精摄入量。

获取原文
获取原文并翻译 | 示例

摘要

It is common to treat some diseases with more than one medication simultaneously. Since more than one neurotransmitter system is involved in alcohol-seeking behaviour, then a therapeutic approach that targets more than one system should be more effective in reducing alcohol intake than one addressing a single system. To test this hypothesis, we compared the efficacy of low doses of individual drugs reported to reduce voluntary alcohol drinking to the efficacy of a mixture of these agents at the same low doses in reducing alcohol intake in three strains of alcohol-preferring rats (P, HAD, and Fawn-Hooded). After establishment of a stable baseline for alcohol intake in a continuous access paradigm, each rat received separate single i.p. injections of relatively low doses of either naltrexone (2.0 mg/kg), fluoxetine (1.0 mg/kg), the thyrotropin-releasing hormone analogue TA-0910 (0.2 mg/kg), a mixture of all three drugs, or the vehicle at 09:30. Each rat received all treatments, with an inter-injection washout period of at least 3 days. Alcohol and water intakes were measured at 6 and 24 h, and food intake was measured at 24 h, after the injection. Our results show that individual drugs did not significantly affect food, water, or alcohol intake. However, the mixture significantly reduced alcohol intake in all three strains, but had no effect on food intake. Similar results were obtained when the HAD rats received an oral dose of the individual drugs or the mixture. When P rats were given an i.p. injection of the mixture for 10 consecutive days, there was a continued suppressing effect. These findings show that a combination treatment designed to target simultaneously serotonergic, dopaminergic, and opioidergic systems can reduce alcohol intake, even though the doses of the individual drugs in the mixture are relatively low and ineffective when given singly.
机译:通常同时使用多种药物治疗某些疾病。由于寻求酒精的行为涉及一种以上的神经递质系统,因此针对一种以上系统的治疗方法在减少酒精摄入方面应比针对单一系统的方法更为有效。为了验证这一假设,我们比较了三种酒精偏爱的品系中,据报道低剂量的个别药物可减少自愿饮酒的功效与相同剂量低剂量的这些药物混合物在减少酒精摄入中的功效(P, HAD和Fawn-Hooded)。在连续访问范式中建立稳定的酒精摄入基线后,每只大鼠接受单独的腹膜内注射。注射相对较低剂量的纳曲酮(2.0 mg / kg),氟西汀(1.0 mg / kg),促甲状腺激素释放激素类似物TA-0910(0.2 mg / kg),所有三种药物的混合物或09:30。每只大鼠接受所有治疗,注射间冲洗期至少为3天。注射后6小时和24小时测量酒精和水摄入量,并在24小时测量食物摄入量。我们的结果表明,个别药物并未显着影响食物,水或酒精的摄入量。但是,该混合物显着降低了所有三种菌株的酒精摄入量,但对食物摄入量没有影响。当HAD大鼠口服单个药物或混合物的剂量时,获得了相似的结果。当P只大鼠接受腹膜内注射时。连续10天注射混合物,具有持续的抑制作用。这些发现表明,设计用于同时针对血清素能,多巴胺能和卵磷脂的系统的联合治疗可减少酒精摄入,即使混合物中单个药物的剂量相对较低且单次给药无效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号